Variable | Univariate OR (95% CI); P | Multivariate OR (95% CI); P |
---|---|---|
Tumour volume, cm3 | 2.275 (1.21–4.28); 0.011 | 2.221 (1.04–4.74); 0.039 |
Presence of associated cyst Cyst versus no cyst | 0.489 (0.06–3.44); 0.472 | 0.166 (0.01–54.7); 0.544 |
EPO level, mU/ml | 0.982 (0.91–1.05); 0.602 | 0.987 (0.81–1.19); 0.892 |
VHL mutation | ||
Non-truncating versus truncating | 7.180 E8 (0.00–0.00); 0.999 | 5.4 E7 (0.00–0.00); 0.999 |
Miscellaneous versus truncating | 1.469 E8 (0.00–0.00); 0.999 | 7.1 E6 (0.00–0.00); 0.999 |
Concomitant renal cell carcinoma (RCC) RCC versus no RCC | 0.472 (0.05–4.88); 0.529 | 2.790 (0.01–436.9); 0.691 |